Recent articles

Erlotinib (Tarceva®) was the first EGFR tyrokinase inhibitor to be authorized for the treatment of non-small-cell lung carcinoma (NSCLC). It enabled outpatient treatment, and has a more favourable ...

Vector vaccines are produced using a relatively new technology which, among other things,  involves genetic techniques. After the genome of a new virus has been sequenced, this technology enables ...

Several studies have examined the efficacy and adverse effects of amisulpride for patients with schizophrenia, and these studies have been included in several meta-analyses (including network meta ...

The use of apps as medical devices can be advantageous for both patients and care providers, on condition that these products are thoroughly investigated and conform to the requirements for medica ...

A viral outbreak that results in a pandemic requires rapid vaccine development. Messenger-RNA (mRNA) vaccines are prepared using a new technology that is based partly on genetic techniques. After ...

For patients with a fully or partially inactive CYP2C19 enzyme, treatment with ticagrelor or prasugrel for up 12 months after stent placement does not significantly reduce the total number of case ...

Vaccines are administered to healthy persons to prevent diseases. This therefore requires an extra critical attitude regarding possible adverse effects. The scale and duration of pre-authorisation ...

Just like patients with cardiovascular problems, patients who have had a cerebral infarction or TIA are advised to aim for LDL-cholesterol values below 1.8 mmol/L. At the time when this recommenda ...